H-1337 ophthalmic solution

H-1337 ophthalmic solution · Allysta Pharmaceutical

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for H-1337 ophthalmic solution, covering 2021-08-02 to 2021-08-02. Get the full timeline:

Most recent: Clinical Trial Update: H-1337 Ophthalmic Solution Phase 1/2 [Phase 1, Phase 2]